Search results

Narrow your search

Result types

Showing 231 - 240 of 503 for "Regulatory" with applied filters

News & Analysis

Anand and Anand on-boards senior IP lawyer as TM partner

10 April 2024 by Anand and Anand

Anand and Anand on-boards senior IP lawyer as TM partner

News & Analysis

Yang & Yang Solicitors LLP welcomes Dennis Yeung as a new Partner

01 April 2024 by East & Concord Partners

Yang & Yang Solicitors LLP welcomes Dennis Yeung as a new Partner

News & Analysis

New Guidance for Initial Evidence Examination for Taxation Crime

27 March 2024 by ABNR - Indonesia

On 19 January 2024, the Indonesian Directorate General of Taxes (“DGT”) issued a Circular Letter of the Directorate General of Taxes No. SE-1/PJ/2024 (“SE No. 1/2024”) as an implementation to the enactment of Minister of Finance of the Republic of Indonesia Regulation No. 177/PMK.03/2022 concerning Procedures for Examining Initial Evidence of Criminal Acts in the Tax Sector which has been effective starting from 3 February 2023 (“PMK No. 177/2022”). PMK No. 177/2022 stipulates several updates which are reflected in SE No. 1/2024 including among other provisions related to (a) the time limit for submitting the initial evidence examination report which must be submitted no later than 1 (one) month before the examination period ends and (b) limitation on the extension period for the initial evidence examination into 12 (twelve) months. In general, SE No. 1/2024 establishes internal technical guidelines for DGT in conducting examinations of evidence of the initiation of tax crimes. This publication aims to provide a preliminary overview concerning the initial evidence examination for taxation crime under SE No. 1/2024.

News & Analysis

First Insights into China’s New Corporate Landscape

05 January 2024 by Ray SHI, Claire XU

Barely a week ago on December 29, 2023, China’s legislative body passed and President Xi Jinping signed into law the newly revised Company Law, effective from July 1, 2024 (the “New Law”).

News & Analysis

Anatomy of Licensing Deals from China Regulatory Perspective

04 January 2024 by Aaron GU, Pengfei YOU, Duzhiyun ZHENG, Yuzhen ZHANG, Fengqi YU

Driven by the passion and belief, and fraught with various risks and challenges, the research and development of innovative drugs and medical devices is a journey that’s never easy.

News & Analysis

Foreign Acquisition of Chinese State-Owned Enterprises

03 January 2024 by Hui Ye Law Firm - China

Wu Dong and Sun Xiaoning from Hui Ye Law Firm highlight a number of considerations that warrant particular attention from foreign investors seeking to acquire state-owned enterprises in China.

News & Analysis

ESG Banking Products in China — (I) Green Deposits

03 January 2024 by Ting ZHENG, Raymond YAN, Eryin YING, Lin ZHU

ESG is in high alignment with China’s “dual carbon” goals and has become an important indicator for measuring the sustainable and high-quality development of enterprises in China

News & Analysis

KFTC proposes ex-ante regulation of platforms under the “Platform Competition Promotion Act”

02 January 2024 by Lee & Ko - South Korea

On December 19, 2023, the Korea Fair Trade Commission (“KFTC”) announced its proposal to enact the “Platform Competition Promotion Act” (“PCPA”) for ex-ante regulation of platforms by designating “dominant platform operators.”

News & Analysis

Roche v DCGI: Delhi High Court on Rejection of Plaints and Doctrine of Passing Off

21 December 2023 by Manisha Singh (Partner) & Neha Ruhela (Senior Associate)

The Delhi High Court, in F Hoffmann-La Roche & others v. Drugs Controller General of India & others (2023:DHC:6522), dismissed applications filed by Cadila Healthcare and Hetero Drugs seeking rejection of the plaints in Roche’s suits

News & Analysis

Yuen Law Shortlisted As Finalist for ALB Regulatory Law Firm of the Year

15 September 2023 by Yuen Law

Yuen Law has been shortlisted as finalist for the prestigious Regulatory Law Firm of the Year award at the Asian Legal Business (ALB) Pan Asian Regulatory Summit Awards 2023/2024.